These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31072570)

  • 1. Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.
    Nagaraju CK; Robinson EL; Abdesselem M; Trenson S; Dries E; Gilbert G; Janssens S; Van Cleemput J; Rega F; Meyns B; Roderick HL; Driesen RB; Sipido KR
    J Am Coll Cardiol; 2019 May; 73(18):2267-2282. PubMed ID: 31072570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin ανβ5 in vitro inhibition limits pro-fibrotic response in cardiac fibroblasts of spontaneously hypertensive rats.
    Perrucci GL; Barbagallo VA; Corlianò M; Tosi D; Santoro R; Nigro P; Poggio P; Bulfamante G; Lombardi F; Pompilio G
    J Transl Med; 2018 Dec; 16(1):352. PubMed ID: 30541573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible and irreversible differentiation of cardiac fibroblasts.
    Driesen RB; Nagaraju CK; Abi-Char J; Coenen T; Lijnen PJ; Fagard RH; Sipido KR; Petrov VV
    Cardiovasc Res; 2014 Mar; 101(3):411-22. PubMed ID: 24368833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts.
    Campbell SE; Katwa LC
    J Mol Cell Cardiol; 1997 Jul; 29(7):1947-58. PubMed ID: 9236148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
    Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
    Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
    Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
    Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
    ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
    Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
    Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
    Ma J; Ma SY; Ding CH
    Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
    Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
    Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
    Cavin S; Maric D; Diviani D
    Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart.
    Rubino M; Travers JG; Headrick AL; Enyart BT; Lemieux ME; Cavasin MA; Schwisow JA; Hardy EJ; Kaltenbacher KJ; Felisbino MB; Jonas E; Ambardekar AV; Bristow MR; Koch KA; McKinsey TA
    Circ Res; 2023 Jan; 132(1):10-29. PubMed ID: 36475698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
    Engebretsen KV; Lunde IG; Strand ME; Waehre A; Sjaastad I; Marstein HS; Skrbic B; Dahl CP; Askevold ET; Christensen G; Bjørnstad JL; Tønnessen T
    FEBS J; 2013 May; 280(10):2382-98. PubMed ID: 23480731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
    López B; González A; Lindner D; Westermann D; Ravassa S; Beaumont J; Gallego I; Zudaire A; Brugnolaro C; Querejeta R; Larman M; Tschöpe C; Díez J
    Cardiovasc Res; 2013 Jul; 99(1):111-20. PubMed ID: 23619422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction.
    Nagaraju CK; Dries E; Popovic N; Singh AA; Haemers P; Roderick HL; Claus P; Sipido KR; Driesen RB
    Sci Rep; 2017 Sep; 7(1):10801. PubMed ID: 28883544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast-Specific Proteotranscriptomes Reveal Distinct Fibrotic Signatures of Human Sinoatrial Node in Nonfailing and Failing Hearts.
    Kalyanasundaram A; Li N; Gardner ML; Artiga EJ; Hansen BJ; Webb A; Freitas MA; Pietrzak M; Whitson BA; Mokadam NA; Janssen PML; Mohler PJ; Fedorov VV
    Circulation; 2021 Jul; 144(2):126-143. PubMed ID: 33874740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
    Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
    Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
    Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.